Cargando…

Efficacy comparison between long-term high-dose praziquantel and surgical therapy for cerebral sparganosis: A multicenter retrospective cohort study

BACKGROUND: Sparganosis is a parasitic infection caused by the plerocercoid larvae of Spirometra mansoni in East and Southeast Asia. The plerocercoid larvae sometimes invade the encephalon, resulting in severe cerebral sparganosis. Surgical removal of the larvae is considered a standard therapy for...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Daojun, Xie, Huiqun, Wan, Hui, An, Ning, Xu, Chunhua, Zhang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211769/
https://www.ncbi.nlm.nih.gov/pubmed/30346956
http://dx.doi.org/10.1371/journal.pntd.0006918
_version_ 1783367406788280320
author Hong, Daojun
Xie, Huiqun
Wan, Hui
An, Ning
Xu, Chunhua
Zhang, Jun
author_facet Hong, Daojun
Xie, Huiqun
Wan, Hui
An, Ning
Xu, Chunhua
Zhang, Jun
author_sort Hong, Daojun
collection PubMed
description BACKGROUND: Sparganosis is a parasitic infection caused by the plerocercoid larvae of Spirometra mansoni in East and Southeast Asia. The plerocercoid larvae sometimes invade the encephalon, resulting in severe cerebral sparganosis. Surgical removal of the larvae is considered a standard therapy for cerebral sparganosis. In contrast, the efficacy and safety of long-term, high-dose praziquantel treatment for cerebral sparganosis have not been explored. METHODOLOGY/PRINCIPAL FINDINGS: In this multicenter retrospective study, we assessed the records of 96 patients with cerebral sparganosis who consulted at three medical centers from 2013 to 2017. Forty-two patients underwent surgical lesion removal, and the other 54 patients received long-term, high-dose praziquantel (50 mg/kg/day for 10 days, repeated at monthly intervals). The primary outcome was the complete disappearance of active lesions on cerebral magnetic resonance imaging. The secondary outcomes included the modified Rankin scale score at 90 days, incidence of seizure, eosinophil count, and serological Spirometra. mansoni antibody titer. The efficacy of praziquantel treatment was similar to that of surgical lesion removal for cerebral sparganosis with respect to both the primary outcome and secondary outcomes. Although binary logistic regression models also supported the primary outcome after adjustment for age, sex, lesion location, and loss to follow-up, some unavoidable confounders might have biased the statistical power. No significant clinical complications or laboratory side effects occurred in the praziquantel group with the exception of a relatively benign allergic reaction. CONCLUSIONS/SIGNIFICANCE: In this small-sample, nonrandomized, retrospective exploratory study, some patients with cerebral sparganosis were responsive to long-term, high-dose praziquantel with an efficacy similar to that of surgical lesion removal. These findings increase the treatment flexibility for this serious infection.
format Online
Article
Text
id pubmed-6211769
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-62117692018-11-19 Efficacy comparison between long-term high-dose praziquantel and surgical therapy for cerebral sparganosis: A multicenter retrospective cohort study Hong, Daojun Xie, Huiqun Wan, Hui An, Ning Xu, Chunhua Zhang, Jun PLoS Negl Trop Dis Research Article BACKGROUND: Sparganosis is a parasitic infection caused by the plerocercoid larvae of Spirometra mansoni in East and Southeast Asia. The plerocercoid larvae sometimes invade the encephalon, resulting in severe cerebral sparganosis. Surgical removal of the larvae is considered a standard therapy for cerebral sparganosis. In contrast, the efficacy and safety of long-term, high-dose praziquantel treatment for cerebral sparganosis have not been explored. METHODOLOGY/PRINCIPAL FINDINGS: In this multicenter retrospective study, we assessed the records of 96 patients with cerebral sparganosis who consulted at three medical centers from 2013 to 2017. Forty-two patients underwent surgical lesion removal, and the other 54 patients received long-term, high-dose praziquantel (50 mg/kg/day for 10 days, repeated at monthly intervals). The primary outcome was the complete disappearance of active lesions on cerebral magnetic resonance imaging. The secondary outcomes included the modified Rankin scale score at 90 days, incidence of seizure, eosinophil count, and serological Spirometra. mansoni antibody titer. The efficacy of praziquantel treatment was similar to that of surgical lesion removal for cerebral sparganosis with respect to both the primary outcome and secondary outcomes. Although binary logistic regression models also supported the primary outcome after adjustment for age, sex, lesion location, and loss to follow-up, some unavoidable confounders might have biased the statistical power. No significant clinical complications or laboratory side effects occurred in the praziquantel group with the exception of a relatively benign allergic reaction. CONCLUSIONS/SIGNIFICANCE: In this small-sample, nonrandomized, retrospective exploratory study, some patients with cerebral sparganosis were responsive to long-term, high-dose praziquantel with an efficacy similar to that of surgical lesion removal. These findings increase the treatment flexibility for this serious infection. Public Library of Science 2018-10-22 /pmc/articles/PMC6211769/ /pubmed/30346956 http://dx.doi.org/10.1371/journal.pntd.0006918 Text en © 2018 Hong et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Hong, Daojun
Xie, Huiqun
Wan, Hui
An, Ning
Xu, Chunhua
Zhang, Jun
Efficacy comparison between long-term high-dose praziquantel and surgical therapy for cerebral sparganosis: A multicenter retrospective cohort study
title Efficacy comparison between long-term high-dose praziquantel and surgical therapy for cerebral sparganosis: A multicenter retrospective cohort study
title_full Efficacy comparison between long-term high-dose praziquantel and surgical therapy for cerebral sparganosis: A multicenter retrospective cohort study
title_fullStr Efficacy comparison between long-term high-dose praziquantel and surgical therapy for cerebral sparganosis: A multicenter retrospective cohort study
title_full_unstemmed Efficacy comparison between long-term high-dose praziquantel and surgical therapy for cerebral sparganosis: A multicenter retrospective cohort study
title_short Efficacy comparison between long-term high-dose praziquantel and surgical therapy for cerebral sparganosis: A multicenter retrospective cohort study
title_sort efficacy comparison between long-term high-dose praziquantel and surgical therapy for cerebral sparganosis: a multicenter retrospective cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211769/
https://www.ncbi.nlm.nih.gov/pubmed/30346956
http://dx.doi.org/10.1371/journal.pntd.0006918
work_keys_str_mv AT hongdaojun efficacycomparisonbetweenlongtermhighdosepraziquantelandsurgicaltherapyforcerebralsparganosisamulticenterretrospectivecohortstudy
AT xiehuiqun efficacycomparisonbetweenlongtermhighdosepraziquantelandsurgicaltherapyforcerebralsparganosisamulticenterretrospectivecohortstudy
AT wanhui efficacycomparisonbetweenlongtermhighdosepraziquantelandsurgicaltherapyforcerebralsparganosisamulticenterretrospectivecohortstudy
AT anning efficacycomparisonbetweenlongtermhighdosepraziquantelandsurgicaltherapyforcerebralsparganosisamulticenterretrospectivecohortstudy
AT xuchunhua efficacycomparisonbetweenlongtermhighdosepraziquantelandsurgicaltherapyforcerebralsparganosisamulticenterretrospectivecohortstudy
AT zhangjun efficacycomparisonbetweenlongtermhighdosepraziquantelandsurgicaltherapyforcerebralsparganosisamulticenterretrospectivecohortstudy